Appropriate solution selection at the administering epirubicin hydrochloride to the breast cancer patients

被引：2
|
作者：
Masuda, N. [1 ]
Amani, S. [2 ]
Nishikata, M. [3 ]
Matsuyama, K. [3 ]
Tsujinaka, T. [1 ]
机构：
[1] Osaka Natl Hosp, Osaka, Japan
[2] Sakai Municipal Hosp, Sakai, Osaka, Japan
[3] Mukogawa Womens Univ, Sch Pharmaceut Sci, Ashiya, Japan
来源：
EJC SUPPLEMENTS | 2004年 / 2卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(04)90912-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
309
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [21] Epirubicin approved for breast cancer treatment
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (21) : 2177 - 2177
  • [22] Towards appropriate local surgery for patients with breast cancer
    Sainsbury, R
    LANCET, 2000, 356 (9236): : 1124 - 1125
  • [23] Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
    Kerstin Wimmer
    Monika Sachet
    Cristiano Ramos
    Sophie Frantal
    Hanna Birnleitner
    Christine Brostjan
    Ruth Exner
    Martin Filipits
    Zsuzsanna Bago-Horvath
    Margaretha Rudas
    Rupert Bartsch
    Michael Gnant
    Christian F. Singer
    Marija Balic
    Daniel Egle
    Rudolf Oehler
    Florian Fitzal
    Journal of Experimental & Clinical Cancer Research, 42
  • [24] Epirubicin as adjuvant therapy for breast cancer
    Suh, C
    CANCER PRACTICE, 2001, 9 (02) : 104 - 106
  • [25] Appropriate dosing of pilsicainide hydrochloride in patients on hemodialysis
    Matsumoto, M
    Fujii, Z
    Kawata, Y
    Sakumura, T
    Minami, M
    Fujimoto, K
    Nawata, C
    Matsuzaki, M
    NEPHRON, 2001, 88 (02): : 134 - 137
  • [26] Genetic Algorithm Based Selection of Appropriate Biomarkers for Improved Breast Cancer Prediction
    Mishra, Arnab Kumar
    Roy, Pinki
    Bandyopadhyay, Sivaji
    INTELLIGENT SYSTEMS AND APPLICATIONS, VOL 2, 2020, 1038 : 724 - 732
  • [27] Change of formulation decreases venous irritation in breast cancer patients receiving epirubicin
    Nagata, Kenichiro
    Egashira, Nobuaki
    Yamada, Takaaki
    Watanabe, Hiroyuki
    Yamauchi, Yui
    Oishi, Ryozo
    SUPPORTIVE CARE IN CANCER, 2012, 20 (05) : 951 - 955
  • [28] Therapeutic effects of epirubicin combined with capecitabine for patients with triple negative breast cancer
    Zhang, Yan
    Ye, Zhen
    Chen, Zhongnan
    Yang, Meng
    Yu, Dapeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (10): : 12400 - 12409
  • [29] Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients
    Esposito, M
    Venturini, M
    Vannozzi, MO
    Tolino, G
    Lunardi, G
    Garrone, O
    Angiolini, C
    Viale, M
    Bergaglio, M
    Del Mastro, L
    Rosso, R
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) : 1132 - 1140
  • [30] Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients
    Michelotti, A
    Venturini, M
    Tibaldi, C
    Bengala, C
    Gallo, L
    Carnino, F
    Del Mastro, L
    Lionetto, R
    Montanaro, E
    Rosso, R
    Conte, P
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 59 (02) : 133 - 139
12345